Anti-chlamydial IgG Neutralizing Ability in Nonzoonotic Atypical Community Acquired Respiratory Tract Infections
Tóm tắt
Chlamydophila pneumoniae is a pathogenic agent, involved in various types of infection. This study has evaluated the ability of IgG antibodies in outpatient, with acute respiratory tract infections from C. pneumoniae, to neutralize in vitro purified elementary bodies of this bacterium, revealing a good neutralizing performance of IgG antibodies.
Tài liệu tham khảo
Mitchell CM, Hutton S, Myers GSA, Brunham R, Timms P (2010) Chlamydia pneumoniae is genetically diverse in animals and appears to have crossed the host barrier to humans on (at least) two occasions. PLoS Pathog 6:e1000903. doi:10.1371/journal.ppat.1000903
Grayston JT, Kuo CC, Wang SP, Altman J (1986) A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med 315:161–168. doi:10.1056/NEJM198607173150305
Miyashita N, Fukano H, Okimoto N, Hara H, Yoshida K, Niki Y, Matsushima T (2002) Clinical presentation of community-acquired Chlamydia pneumoniae pneumonia in adults. Chest 121:1776–1781. doi:10.1378/chest.121.6.1776
Kuo CC, Jackson LA, Campbell LA, Grayston JT (1995) Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 8:451–461
Boman J, Hammerschlag MR (2002) Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies. Clin Microbiol Rev 15:1–20. doi:10.1128/CMR.15.1.1-20.2002
Busatto P, Blasi F, Casanova F, Selmi C, Centanni S, Zuin M (2005) Lack of PBC-specific antimitochondrial antibodies in patients with Chlamydia pneumoniae infection. J Gastroenterol Hepatol 20:1626–1627. doi:10.1111/j.1440-1746.2005.03941.x
Fainardi E, Castellazzi M, Seraceni S, Granieri E, Contini C (2008) Under the microscope: focus on Chlamydia pneumoniae infection and multiple sclerosis. Curr Neurovasc Res 5:60–70. doi:10.2174/156720208783565609
Pignanelli S, Shurdhi A, Delucca F, Donati M (2009) Simultaneous use of direct and indirect diagnostic techniques in atypical respiratory infections from Chlamydophila pneumoniae and Mycoplasma pneumoniae. J Clin Lab Anal 23:206–209. doi:10.1002/jcla.20332
Pignanelli S, Pulcrano G, Iula VD, Zaccherini P, Testa A, Catania MR (2014) In vitro antimicrobial profile of Ureaplasma urealyticum from genital tract of childbearing-aged women in northern and southern Italy. APMIS 122:552–555. doi:10.1111/apm.12184
Donati M, Di Francesco A, Baldelli R, Magnino S, Pignanelli S, Shurdhi A, Delucca F, Cevenini R (2009) In vitro detection of neutralising antibodies to Chlamydia suis in pig sera. Vet Rec 164:173–174. doi:10.1136/vr.164.6.173
Pignanelli S, Shurdhi A (2011) In vitro activity of rifaximin against Chlamydia suis. Vet Rec 169:584. doi:10.1136/vr.100027
Bartolini E, Ianni E, Frigimelica E, Petracca R, Galli G, Berlanda Scorza F, Norais N, Laera D, Giusti F, Pierleoni A, Donati M, Cevenini R, Finco O, Grandi G, Grifantini R (2013) Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro. J Extracell Vesicles. doi:10.3402/jev.v2i0.20181
Phoon MC, Yee GW, Koh WP, Chow VT (2011) Comparative seroepidemiologic analysis of Chlamydophila Pneumoniae infection using microimmunofluorescence, enzyme immunoassay and neutralization test: implications for serodiagnosis. Indian J Microbiol 51:223–229. doi:10.1007/s12088-011-0168-4
Baud D, Regan L, Greub G (2010) Comparison of five commercial serological tests for the detection of anti-Chlamydia trachomatis antibodies. Eur J Clin Microbiol Infect Dis 29:669–675. doi:10.1007/s10096-010-0912-4
Pignanelli S (2011) Laboratory diagnosis of Toxoplasma gondii infection with direct and indirect diagnostic techniques. Indian J Pathol Microbiol 54:786–789. doi:10.4103/0377-4929.91503